Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

NEXT STORY
Plus Therapeutics to Present at MedInvest Oncology Investor Conference
PREV STORY
Veru Reports Record Fiscal 2021 Full-Year Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Histogenics Corporation Announces Second Quarter 2017 Financial and Operating Results

‒ Completed Enrollment in NeoCart® Phase 3 Clinical Trial ‒‒ Top-line Data and Potential ...

author_avatar
NASDAQ Market News

NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder

FT. MYERS, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a ...

author_avatar
NASDAQ Market News

CEPI Awards $25 Million Contract to Profectus BioSciences and Emergent BioSolutions to Develop Nipah Virus Vaccine

OSLO, Norway and BALTIMORE and GAITHERSBURG, Md., May 27, 2018 (GLOBE NEWSWIRE) -- CEPI—the ...

author_avatar
NASDAQ Market News